© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 27, 2021
Although there are several conditions known to be risk factors for clostridium difficile, data on the link between malignancy and clostridium difficile are limited.
September 15, 2021
Individuals in a study who received the food with BB-12 probiotic retained beneficial metabolites produced by the microbiota.
September 14, 2021
Ten quiz questions to assess your knowledge on common symptoms and treatments for Clostridioides difficile.
September 07, 2021
From an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.
September 02, 2021
A study found individuals receiving probiotics had a decrease in C. difficile diagnosed in stool samples than those who did not receive probiotics.
August 26, 2021
The treatment was also well-tolerated, with a similar safety profile to placebo, according to the investigators.
August 24, 2021
Hospitalizations related to C. diff infections can cost more than twice as much as the average hospitalization and can extend patients’ stays by an average of 3.6 days.
August 17, 2021
Ridinilazole is not currently approved for use by any regulatory authority.
August 06, 2021
C difficile colonization rates among children were greatest at 6 to 12 months of age but decreased among children older than 5 years of age.
July 28, 2021
Bezlotoxumab is administered to prevent Clostridium difficile infection from recurring in patients who are receiving treatment for the infection and are at risk for recurrence.